Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
10 Jul 2024 07:45 CEST |
REALITES | Bauer Stadium : REALITES entering Exclusive Negotiations with TODD INTERESTS | 35101010 Real Estate Holding and Development | News contracts |
10 Jul 2024 07:32 CEST |
TIPIAK | Communiqué normé de C2 DEVELOPPEMENT relatif à la mise à disposition de la note d\'information et du document Autres Informations de C2 DEVELOPPEMENT | 45102020 Food Products | Other subject |
10 Jul 2024 07:31 CEST |
TIPIAK | Communiqué normé de TIPIAK relatif à la mise à disposition de la note en réponse et du document Autres Informations de TIPIAK | 45102020 Food Products | Other subject |
10 Jul 2024 07:31 CEST |
VALLOUREC | Vallourec wins a major order from TotalEnergies in Angola | 60101030 Oil Equipment and Services | News contracts |
10 Jul 2024 07:31 CEST |
VALLOUREC | Vallourec remporte une commande majeure de TotalEnergies en Angola | 60101030 Oil Equipment and Services | News contracts |
10 Jul 2024 07:30 CEST |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
10 Jul 2024 07:30 CEST |
KLEA HOLDING | Portés par un nouveau trimestre de forte croissance, Klea Holding et sa filiale Smart Salem confirment leur belle trajectoire et clôturent le premier semestre avec un volume de tests médicaux en hausse de 23% | 20102010 Medical Equipment | Legal |
10 Jul 2024 07:30 CEST |
CROSSJECT | Crossject is awarded a 6.9 million euros financing from the French Government, as part of the France 2030 innovation plan, to accelerate the development of ZENEO® Epinephrine | 20102010 Medical Equipment | - |
10 Jul 2024 07:30 CEST |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
10 Jul 2024 07:30 CEST |
KLEA HOLDING | Klea Holding and its subsidiary Smart Salem close the first half of 2024 with 23% growth. | 20102010 Medical Equipment | Legal |
10 Jul 2024 07:30 CEST |
CROSSJECT | Crossject obtient 6,9 millions d'euros de financement public dans le cadre du plan France 2030, pour accélérer le développement de ZENEO® Adrénaline | 20102010 Medical Equipment | - |
10 Jul 2024 07:06 CEST |
BlueNord ASA | BlueNord Announce Second Quarter and First Half 2024 Results | 60101010 Oil: Crude Producers | Half yearly financial reports and audit reports/limited reviews |
10 Jul 2024 07:00 CEST |
AKER CARBON CAPTURE ASA | Aker Carbon Capture ASA: Second quarter 2024 results | 50202030 Electronic Equipment: Pollution Control | Half yearly financial reports and audit reports/limited reviews |
10 Jul 2024 07:00 CEST |
CHARGEURS | CHARGEURS - Outstanding commercial momentum for Chargeurs Museum Studio | 50203000 Diversified Industrials | Legal |
10 Jul 2024 07:00 CEST |
VITURA | Vitura Announces the Sale of a Majority Stake in the Passy Kennedy and Office Kennedy Holding Companies | 35102030 Office REITs | Other subject |
10 Jul 2024 07:00 CEST |
PETRONOR E&P ASA | PetroNor E&P ASA: Q2 2024 Production update | 60101010 Oil: Crude Producers | Non-regulatory press releases |
10 Jul 2024 07:00 CEST |
DNO ASA | DNO Powers on in Kurdistan | 60101010 Oil: Crude Producers | Additional regulated information required to be disclosed under the laws of a Member State |
10 Jul 2024 07:00 CEST |
Kongsberg Gruppen ASA | 21 PROSENT VEKST OG EBIT PÅ 1,45 MILLIARDER KRONER I KVARTALET | 50203000 Diversified Industrials | Annen informasjonspliktig regulatorisk informasjon |
10 Jul 2024 07:00 CEST |
CHARGEURS | CHARGEURS - Dynamique commerciale spectaculaire pour Chargeurs Museum Studio | 50203000 Diversified Industrials | Legal |
10 Jul 2024 07:00 CEST |
VITURA | Vitura annonce la cession d’une participation majoritaire dans les sociétés détenant les actifs Passy Kennedy et Office Kennedy | 35102030 Office REITs | Other subject |
10 Jul 2024 07:00 CEST |
Kongsberg Gruppen ASA | 21 PER CENT GROWTH AND EBIT OF NOK 1.45 BILLION IN THE QUARTER | 50203000 Diversified Industrials | Additional regulated information required to be disclosed under the laws of a Member State |
09 Jul 2024 22:15 CEST |
NANOBIOTIX | Voting Rights and Shares Capital of the Company | 20103010 Biotechnology | Share history |
09 Jul 2024 22:15 CEST |
NANOBIOTIX | Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social | 20103010 Biotechnology | Share history |
09 Jul 2024 22:10 CEST |
GENFIT | GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial | 20103010 Biotechnology | Other subject |
09 Jul 2024 22:10 CEST |
GENFIT | GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial | 20103010 Biotechnology | Other subject |
09 Jul 2024 20:45 CEST |
ACTICOR BIOTECH | Acticor Biotech publie ses résultats financiers annuels 2023 | 20103010 Biotechnology | Sales |
09 Jul 2024 20:45 CEST |
ACTICOR BIOTECH | Acticor Biotech publishes its 2023 annual results | 20103010 Biotechnology | Sales |
09 Jul 2024 20:20 CEST |
WEBSTEP | Webstep ASA: Closing of the sale of Webstep AB | 10101010 Computer Services | Additional regulated information required to be disclosed under the laws of a Member State |
09 Jul 2024 19:18 CEST |
ONWARD MEDICAL | ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy | 20101025 Health Services | - |
09 Jul 2024 19:01 CEST |
AKER SOLUTIONS | Aker Solutions ASA: Transactions made under the buy-back programme | 60101030 Oil Equipment and Services | Acquisition or disposal of the issuer’s own shares |
09 Jul 2024 19:00 CEST |
PLASTICOS COMPUESTOS S.A. (KOMPUESTOS) | Siginificant shareholdings as of 30 June 2024. | 50203015 Plastics | Share history |
09 Jul 2024 18:50 CEST |
GIGANTE SALMON AS | Gigante Salmon AS – Preliminary result of the Subsequent Offering | 45102010 Farming, Fishing, Ranching and Plantations | Additional regulated information required to be disclosed under the laws of a Member State |
09 Jul 2024 18:32 CEST |
PUBLICIS GROUPE S.A. | Bilan semestriel du contrat de liquidité de Publicis Groupe | 40301020 Media Agencies | Other subject |
09 Jul 2024 18:32 CEST |
PUBLICIS GROUPE S.A. | Publicis Groupe: Half-Year Liquidity Contract Statement | 40301020 Media Agencies | Other subject |
09 Jul 2024 18:30 CEST |
DEKUPLE | DÉKUPLE annonce l'acquisition de Ereferer, plateforme automatisée de Netlinking, par Rocket Marketing | 40301020 Media Agencies | Mergers, Acquiqitions, Transferts |
09 Jul 2024 18:30 CEST |
DEKUPLE | DÉKUPLE announces the acquisition of Ereferer, an automated netlinking platform, by Rocket Marketing | 40301020 Media Agencies | Mergers, Acquiqitions, Transferts |
09 Jul 2024 18:19 CEST |
DAMARTEX | DAMARTEX / Droits de vote bruts et réels au 30 juin 2024 | 40401020 Apparel Retailers | Other subject |
09 Jul 2024 18:19 CEST |
SHELL PLC | Transaction in Own Shares | 60101000 Integrated Oil and Gas | Other subject |
09 Jul 2024 18:15 CEST |
CRCAM PARIS ET IDF | Crédit Agricole d'Ile-de-France : bilan semestriel du contrat de liquidité au 30.06.2024 | 30101010 Banks | Share history |
09 Jul 2024 18:08 CEST |
DEEZER | Half-year report on Deezer’s liquidity contract with BNP Paribas | 40301035 Radio and TV Broadcasters | Other subject |
09 Jul 2024 18:08 CEST |
DEEZER | Bilan semestriel du contrat de liquidité de Deezer avec BNP Paribas | 40301035 Radio and TV Broadcasters | Other subject |
09 Jul 2024 18:05 CEST |
DEEZER | Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 juin 2024 | 40301035 Radio and TV Broadcasters | Other subject |
09 Jul 2024 18:05 CEST |
DEEZER | Information concerning the total number of voting rights and shares in the share capital as of June 30, 2024 | 40301035 Radio and TV Broadcasters | Other subject |
09 Jul 2024 18:02 CEST |
ESKER | La suite Source-to-Pay d’Esker s’étoffe avec de nouvelles fonctionnalités axées sur la croissance durable des entreprises | 10101015 Software | - |
09 Jul 2024 18:00 CEST |
TME PHARMA | TME Pharma N.V. : MESSAGE DU CEO - S1 2024 | 20103010 Biotechnology | Other subject |
09 Jul 2024 18:00 CEST |
IPSEN | Ipsen - June 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital | 20103015 Pharmaceuticals | Share history |
09 Jul 2024 18:00 CEST |
IMPLANET | IMPLANET Reports Revenue of €4.1 Million in the First Half of 2024 | 20102010 Medical Equipment | Other subject |
09 Jul 2024 18:00 CEST |
IPSEN | IPSEN - Buy-back programme - Art 5 of MAR - Week 27 - 2024 | 20103015 Pharmaceuticals | Share history |
09 Jul 2024 18:00 CEST |
COVIVIO | Covivio - Bilan semestriel du contrat de liquidité au 30 juin 2024 | 35102030 Office REITs | Other subject |
09 Jul 2024 18:00 CEST |
ORANGE | Total number of shares and voting rights at June 30, 2024 | 15102015 Telecommunications Services | Corporate life |